Daniel Laajala - UTU Research Portal

Daniel Laajala

- Docent,
Applied mathematics (Department of Mathematics and Statistics)

teelaa@utu.fi

+358 29 450 3805

Vesilinnantie 5

Turku

: https://orcid.org/0000-0002-7016-7354

1 of 3

A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer (2024)
- Journal of Translational Medicine
Mason Mike, Lapuente-Santana Óscar, Halkola Anni S., Wang Wenyu, Mall Raghvendra, Xiao Xu, Kaufman Jacob, Fu Jingxin, Pfeil Jacob, Banerjee Jineta, Chung Verena, Chang Han, Chasalow Scott D., Lin Hung Ying, Chai Rongrong, Yu Thomas, Finotello Francesca, Mirtti Tuomas, Mäyränpää Mikko I., Bao Jie, Verschuren Emmy W., Ahmed Eiman I., Ceccarelli Michele, Miller Lance D., Monaco Gianni, Hendrickx Wouter R. L., Sherif Shimaa, Yang Lin, Tang Ming, Gu Shengqing Stan, Zhang Wubing, Zhang Yi, Zeng Zexian, Das Sahu Avinash, Liu Yang, Yang Wenxian, Bedognetti Davide, Tang Jing, Eduati Federica, Laajala Teemu D., Geese William J., Guinney Justin, Szustakowski Joseph D., Vincent Benjamin G., Carbone David P.
NPEPPS Is a Druggable Driver of Platinum Resistance (2024)
- Cancer Research
Jones Robert T., Scholtes Mathijs, Goodspeed Andrew, Akbarzadeh Maryam, Mohapatra Saswat, Feldman Lily Elizabeth, Vekony Hedvig, Jean Annie, Tilton Charlene B., Orman Michael V., Romal Shahla, Deiter Cailin, Kan Tsung Wai, Xander Nathaniel, Araki Stephanie P., Joshi Molishree, Javaid Mahmood, Clambey Eric T., Layer Ryan, Laajala Teemu D., Parker Sarah J., Mahmoudi Tokameh, Zuiverloon Tahlita C.M., Theodorescu Dan, Costello James C.
ProstaMine: A bioinformatics tool for identifying subtypespecific co-alterations associated with aggressiveness in prostate cancer (2024)
- Frontiers in Pharmacology
Orman Michael, Sreekanth Varsha, Laajala Teemu D., Cramer Scott D., Costello James C.
A harmonized resource of integrated prostate cancer clinical, -omic, and signature features (2023)
- Scientific Data
Laajala Teemu D., Sreekanth Varsha, Soupir Alex C., Creed Jordan H., Halkola Anni S., Calboli Federico C. F., Singaravelu Kalaimathy, Orman Michael V., Colin-Leitzinger Christelle, Gerke Travis, Fridley Brooke L., Tyekucheva Svitlana, Costello James C.
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy (2023)
- Clinical Lung Cancer
Vihinen Hannes, Jokinen Artturi, Laajala Teemu D, Wahid Nesna, Peltola Lotta, Kettunen Tiia, Rönkä Aino, Tiainen Leena, Skyttä Tanja, Kohtamäki Laura, Tulokas Sanni, Karhapää Hanna, Hernberg Micaela, Silvoniemi Maria, Mattila Kalle E
Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland (2023)
- BMC Women's Health
Vauhkonen Paula Katriina, Laajala Teemu Daniel, Lindroos Katarina Mercedes, Mäyränpää Mikko Ilari
Microbiome-based risk prediction in incident heart failure: a community challenge (2023) Erawijantari PP, Kartal E, Liñares-Blanco J, Laajala TD, Feldman LE, Carmona-Saez P, Shigdel R, Claesson MJ, Bertelsen RJ, Gomez-Cabrero D, Minot S, Albrecht J, Chung V, Inouye M, Jousilahti P, Schultz JH, Friederich HC, Knight R, Salomaa V, Niiranen T, Havulinna AS, Saez-Rodriguez J, Levinson RT, Lahti L; FINRISK Microbiome DREAM Challenge and ML4 Microbiome Communities
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin (2023)
- Science Translational Medicine
de Jong Florus C, Laajala Teemu D, Hoedemaeker Robert F, Jordan Kimberley R, van der Made Angelique CJ, Boevé Egbert R, van der Schoot Deric KE, Nieuwkamer Bart, Janssen Emiel AM, Mahmoudi Tokameh, Boormans Joost L, Theodorescu Dan, Costello James C, Zuiverloon Tahlita CM
OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancer (2023)
- PLoS Computational Biology
Halkola Anni S., Joki Kaisa, Mirtti Tuomas, Mäkelä Marko M., Aittokallio Tero, Laajala Teemu D.
High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice (2022)
- iScience
Huhtaniemi Riikka, Sipilä Petra, Junnila Arttu, Oksala Riikka, Knuuttila Matias, Mehmood Arfa, Aho Eija, Laajala Teemu D., Aittokallio Tero, Laiho Asta, Elo Laura, Ohlsson Claes, Thulin Malin H., Kallio Pekka, Mäkelä Sari, Mustonen Mika V.J., Poutanen Matti
Androgen receptor signaling in prostate cancer genomic subtypes (2021)
- Cancers
Jillson Lauren K., Yette Gabriel A., Laajala Teemu D., Tilley Wayne D., Costello James C., Cramer Scott D.
A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma (2021)
- Scientific Reports
Mattila Kalle E., Laajala Teemu D., Tornberg Sara V., Kilpeläinen Tuomas P., Vainio Paula, Ettala Otto, Boström Peter J., Nisen Harry, Elo Laura L., Jaakkola Panu M.
Group polarisation among location-based game players: an analysis of use and attitudes towards game slang (2021)
- Internet Research
Laato Samuli, Inaba Nobufumi, Paloheimo Mauri, Laajala Teemu Daniel
A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions (2020)
- Scientific Data
Gabriel M, Fey V, Heinosalo T, Adhikari P, Rytkönen K, Komulainen T, Huhtinen K, Laajala TD, Siitari H, Virkki A, Suvitie P, Kujari H, Aittokallio T, Perheentupa A, Poutanen M
Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets (2020)
- International Journal of Medical Informatics
Mika Murtojärvi, Anni S. Halkola, Antti Airola, Teemu D. Laajala, Tuomas Mirtti, Tero Aittokallio, Tapio Pahikkala
Do primal instincts explain engagement in location-based games? A hypothesis-forming focus group study on territorial behavior (2020)
- CEUR Workshop Proceedings
Proceedings of the 4th International GamiFIN Conference Samuli Laato, Bastian Kordyaka, Sampsa Rauti, Sonja M. Hyrynsalmi, Marianna Hoikkala, Tarja Pietarinen, Teemu D. Laajala, Mauri Paloheimo, Nobufumi Inaba, Sami Hyrynsalmi
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1 (2020)
- Journal of Biological Chemistry
Kauko O, Imanishi SY, Kulesskiy E, Yetukuri L, Laajala TD, Sharma M, Pavic K, Aakula A, Rupp C, Jumppanen M, Haapaniemi P, Ruan L, Yadav B, Suni V, Varila T, Reimand J, Corthals GL, Aittokallio T, Wennerberg K, Westermarck J
Modeling genetic heterogeneity of drug response and resistance in cancer (2019)
- Current Opinion in Systems Biology
Laajala T., Gerke T., Tyekucheva S., Costello J.
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy (2019)
- Nature Communications
Haikala HM, Anttila JM, Marques E, Raatikainen T, Ilander M, Hakanen H, Ala-Hongisto H, Savelius M, Balboa D, Von Eyss B, Eskelinen V, Munne P, Nieminen AI, Otonkoski T, Schuler J, Laajala TD, Aittokallio T, Sihto H, Mattson J, Heikkila P, Leidenius M, Joensuu H, Mustjoki S, Kovanen P, Eilers M, Leverson JD, Klefstrom J, Klefstrom J
Antiandrogens Reduce Intratumoral Androgen Concentrations and Induce Androgen Receptor Expression in Castration-Resistant Prostate Cancer Xenografts (2018)
- American Journal of Pathology
Knuuttila M, Mehmood A, Huhtaniemi R, Yatkin E, Häkkinen MR, Oksala R, Laajala TD, Ryberg H, Handelsman DJ, Aittokallio T, Auriola S, Ohlsson C, Laiho A, Elo LL, Sipilä P, Mäkelä SI, Poutanen M